|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 3426251 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17764092.7 |
| Date of filing the European patent application | 2017-03-09 | |
| (97) | Date of publication of the European application | 2019-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-20 |
| (46) | Date of publication of the claims translation | 2022-06-27 |
| (86) | Number | PCT/US2017/021565 |
| Date | 2017-03-09 |
| (87) | Number | WO 2017/156266 |
| Date | 2017-09-14 |
| (30) | Number | Date | Country code |
| 201662306487 P | 2016-03-10 | US |
| (72) |
KENT, Justine, M. , US
DREVETS, Wayne, C. , US
DE BOER, Peter , BE
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Depresijos gydymo būdai, panaudojant oreksino-2 receptoriaus antagonistus |
| METHODS OF TREATING DEPRESSION USING OREXIN-2 RECEPTOR ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-02-05 | 9 | 208.00 EUR |
| 2026-03-09 |